SCI时时刷

search
Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review
Global Epidemiology of Meningococcal Disease-Causing Serogroups Before and After the COVID-19 Pandemic: A Narrative Review
Invasive meningococcal disease (IMD) is associated with high morbidity and mortality and predominantly caused by five Neis...
Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
Omadacycline for Diverse Infections in China: A Real-World Analysis of Efficacy and Safety
The efficacy and safety of omadacycline have been primarily documented through Phase III clinical trials; however, there a...
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients
Immunocompromised patients suffer from a disproportionate burden of COVID-19-related morbidity and mortality [1]. As such,...
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI
Recurrent Clostridioides difficile infection (rCDI) often occurs after standard-of-care antibiotics. VOWST oral spores (VO...
Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018
Influenza-Associated Excess Mortality and Hospitalization in Germany from 1996 to 2018
Influenza-associated excess mortality and morbidity is commonly estimated using statistical methods. In Germany, the Rober...
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States
Cost-Effectiveness of Baloxavir Marboxil Versus Oseltamivir or no Treatment for the Management of Influenza in the United States
This study sought to evaluate the cost-effectiveness of baloxavir marboxil compared with oseltamivir or no antiviral treat...
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions
Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions
Although real-world studies demonstrate that those prescribed nirmatrelvir/ritonavir (and particularly within 5 d...